Pimavanserin Impurities and its Related Products

Displaying 4 results of Pimavanserin Impurities

Pimavanserin is a medication used to treat hallucinations and delusions associated with Parkinson's disease. However, during the manufacturing process, impurities may be formed that can affect the drug's efficacy or cause harmful side effects. The characterization and control of these impurities are critical for ensuring the safety and quality of the drug product. Various analytical techniques, such as HPLC, LC-MS, and NMR, are used to identify and quantify these impurities. Regulatory agencies also require manufacturers to provide detailed information about the impurities present in the drug substance and drug product.


PIMAVANSERIN IMPURITIES, IMPURITIES
1,3-bis(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)urea


CAT No. : CS-O-42045
Mol F. : C₂₁H₂₅F₂N₃O
Mol W. : 373.44 g/mol
Cas No. : Not Available
Stock : IN-Stock

PIMAVANSERIN IMPURITIES, IMPURITIES
4-​butoxy Pimavanserin impurity


CAT No. : CS-O-41313
Mol F. : C₂₅H₃₄FN₃O₂
Mol W. : 427.56 g/mol
Cas No. : 2377646-59-6
Stock : Enquire

PIMAVANSERIN IMPURITIES, IMPURITIES
Pimavanserin N-Oxide


CAT No. : CS-O-42815
Mol F. : C₂₅H₃₄FN₃O₃
Mol W. : 443.55 g/mol
Cas No. : 1134815-71-6
Stock : IN-Stock

PIMAVANSERIN IMPURITIES, IMPURITIES
Pimavanserin Tartrate Impurity-F


CAT No. : CS-EO-00822
Mol F. : C15H21NO6
Mol W. : 311.33 g/mol
Cas No. : Not Available
Stock : Enquire